University of Philippines Manila

Agreements with 3 industry partners signed on health research and innovations

The Teknolusugan events held on Nov. 25 and 27, 2020 saw the ceremonial signing of agreements between UP Manila and three companies for the next steps of the technology development process.

The first industry partnership was the license agreement between UP Manila and Greenext Lifescience Corporation represented by its president, Mr. Noel Morada. The licensed technology was Hemoxyther, an herbal food and dietary supplement for iron deficiency anemia and other hematological disorders developed by College of Pharmacy professor and Institute of Pharmaceutical Sciences Director Erna Arollado. Greenext Lifescience Corporation is breaking into new frontiers, new areas of science and technology in the Philippines, in addition to its manufacture of personal care products with fresh seaweed as its main component. 
 
This was followed by a research collaboration agreement with Rohto Pharmaceutical Company (Osaka, Japan)  for further development and production of a prototype broad spectrum anti infective ophthalmic solution. Dr Leo Cubillan is the inventor of the technology targeted for the initial management of conjunctivitis in the Philippines seen in almost half of eye patients during consults. The multinational company that develops pharmaceutical products such as eye drops and skin care items was represented by Mr. Takahiro Kurose during the signing.

The third agreement was signed with D & L Industries, a company that manufactures products from food ingredients, chemicals for personal and home care use, raw materials for plastic, and aerosol products. Its President and Chief Operating Officer, Dean Armando Lao, expressed delight to be working with UP Manila and expressed desire to continue the ties between the academe and business in developing technology for Filipinos by the Filipinos. 

The industry partnerships are manifestations of the engaging dealings of UP Manila with companies with whom it forges a mutually beneficial relationship to move forward the health innovation agenda in the country.

“We look forward to more fruitful years of partnerships and collaboration with each of you even beyond this pandemic. Let us become partners towards ensuring the Filipinos’ optimal health by making these technologies accessible to all,” stated UP Manila Chancellor Carmencita D. Padilla.

Cynthia Villamor and Charmaine Lingdas
Published in Healthscape Special COVID-19 Issue No. 20 (30 November 2020)